Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced androgen levels and hair growth in women with hirsutism.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

Inflammation damages sweat ducts, causing sweat gland injury.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

PCOS is common among female health science students, linked to hormonal issues and family history, and early diagnosis is important.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Skin symptoms often reveal hormonal imbalances in PCOS.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Most postmenopausal women experience significant skin changes and various skin conditions.

Hyperandrogenism is a common hormonal disorder in women, often linked to PCOS.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

The April 2016 JEADV issue covered various dermatology topics, including psoriasis, psoriatic arthritis, mTOR inhibitors, autoimmune diseases, photodynamic therapy, viral DNA in skin diseases, chronic hand eczema, and female hair loss.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Antiandrogen treatment helps reduce hair follicles and sebaceous glands in hirsute women.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Hair disorders need a holistic approach, including medical, cosmetic, and psychological support.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.